AXIM - AXIM Biotechnologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue195.61447.57347.05949.139
Cost of Revenue8.51142.857154.1350.387
Gross Profit187.1034.716-107.071-1.248
Operating Expenses
Research Development2,056.1751,352.969235.579571.455
Selling General and Administrative3,163.7151,797.4783,413.4569,475.724
Non Recurring----
Others----
Total Operating Expenses5,231.7573,196.663,806.52110,098.685
Operating Income or Loss-5,036.143-3,149.087-3,759.462-10,049.546
Income from Continuing Operations
Total Other Income/Expenses Net-1,718.503-1,019.116-2,050.444-43.221
Earnings Before Interest and Taxes-5,036.143-3,149.087-3,759.462-10,049.546
Interest Expense-1,578.966-1,020.713-301.446-43.221
Income Before Tax-6,754.646-4,168.203-5,809.906-10,092.767
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-6,754.646-4,168.203-5,809.906-10,092.767
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-6,754.646-4,168.203-5,809.906-10,092.767
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-6,754.646-4,168.203-7,284.906-10,092.767